Ong WL, Cheung P, Chung H, Chu W, et al. To boost or not to boost - pooled analyses from two-fraction stereotactic ablative radiotherapy (SABR) trials for localised prostate cancer. Int J Radiat Oncol Biol Phys 2023 Jul 5:S0360-3016(23)04480.
PMID: 37419394